Separation of active and inactive forms of human antithrombin by heparin affinity chromatography

By Heger A.   Grunert T.   Schulz P.   Josic D.   Buchacher A.  

Thrombosis Research, Vol. 106, Iss. 2, 2002-04 ,pp. : 157-164

Elsevier

Access to resources Recommend Favorite

Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin

By Fredenburgh J.C.   Anderson J.A.M.   Weitz J.I.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 7, 2002-10 ,pp. : 281-287

Elsevier

Access to resources Recommend Favorite

Antithrombin binding by human umbilical vein endothelial cells: effects of exogenous heparin

By Justus A.C.   Roussev R.   Norcross J.L.   Faulk W.P.  

Thrombosis Research, Vol. 79, Iss. 2, 1995-07 ,pp. : 175-186

Elsevier

Access to resources Recommend Favorite

Anticoagulant and Antithrombin Effects of Intimatan, a Heparin Cofactor II Agonist

By Buchanan M.R.   Brister S.J.  

Thrombosis Research, Vol. 99, Iss. 6, 2000-09 ,pp. : 603-612

Elsevier

Access to resources Recommend Favorite

Identification of Critical Molecular Interactions Mediating Heparin Activation of Antithrombin - Implications for the Design of Improved Heparin Anticoagulants

By Olson S.T.   Bjork I.   Bock S.C.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 5, 2002-07 ,pp. : 198-205

Elsevier

Access to resources Recommend Favorite